Corona Remedies Ltd
Company Profile
Business description
Corona Remedies Ltd is a pharmaceutical formulation company engaged in developing, manufacturing, and marketing products in women's healthcare, cardio-diabetes, pain management, urology, and other therapeutic areas. The company offers products across the following therapeutic areas: women's health, cardio-diabetes, pain management, urology, and others/multispecialty pharmaceuticals (comprising VMN, gastrointestinal, and respiratory). The company operates in only one reportable business segment, i.e., pharmaceuticals. It generates a substantial portion of its revenue from operations in certain therapeutic areas in India, with the majority coming from women's healthcare.
Contact
S. G. Highway, CORONA House
C - Mondeal Business Park, Near Gurudwara
Thaltej
AhmedabadGJ380 059
INDT: +91 7940233000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees
4,573
Stocks News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
stocks
Our top ASX picks in every sector
stocks
Which of the 3 giant AI IPOs should you buy?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,786.70 | 113.00 | -1.27% |
| CAC 40 | 7,981.27 | 164.33 | 2.10% |
| DAX 40 | 23,298.89 | 618.85 | 2.73% |
| Dow JONES (US) | 46,565.74 | 224.23 | 0.48% |
| FTSE 100 | 10,364.79 | 188.34 | 1.85% |
| HKSE | 25,058.08 | 235.95 | -0.93% |
| NASDAQ | 21,840.95 | 250.32 | 1.16% |
| Nikkei 225 | 52,731.94 | 1,007.74 | -1.88% |
| NZX 50 Index | 12,881.17 | 55.30 | 0.43% |
| S&P 500 | 6,575.32 | 46.80 | 0.72% |
| S&P/ASX 200 | 8,590.40 | 94.60 | -1.09% |
| SSE Composite Index | 3,926.64 | 21.91 | -0.55% |